{"id":"W2332498410","doi":"10.1016/j.neuropharm.2016.03.036","title":"Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research","year":2016,"lang":"en","type":"review","venue":"Neuropharmacology","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":79,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research; Parkinson Society Canada","keywords":"Metabotropic glutamate receptor; Neuroprotection; Metabotropic receptor; Glutamate receptor; Pharmacology; Allosteric regulation; Neuroscience; Metabotropic glutamate receptor 5; Receptor; Metabotropic glutamate receptor 1; Metabotropic glutamate receptor 2; Glutamatergic; Class C GPCR; Excitotoxicity; Metabotropic glutamate receptor 7; Chemistry; Medicine; Biology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009476651,0.001100304,0.002394055,0.002083419,0.0002290871,0.001377665,0.001027203,0.001282643,0.0034269],"category_scores_gemma":[0.0009602527,0.0003166083,0.0007614093,0.00219905,0.0004566666,0.001781408,0.000846225,0.001912006,0.001692783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004628084,"about_ca_system_score_gemma":0.00116229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008306986,"about_ca_topic_score_gemma":0.00247256,"domain_scores_codex":[0.99977,0.00003464066,0.00005267442,0.00003721859,0.00007860705,0.00002681982],"domain_scores_gemma":[0.9995157,0.0002078197,0.00009117598,0.00001083707,0.0001349235,0.00003963184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002456199,0.0000866933,0.000245677,0.0257814,0.0002242477,0.000403528,0.00006886185,0.0003274118,0.002557822,0.002078441,0.03144193,0.9365383],"study_design_scores_gemma":[0.00009598868,0.0003087894,0.001347162,0.007567561,0.0008402842,0.002826791,0.0001193441,0.000231024,0.0008581412,0.002617655,0.9831337,0.00005351723],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007747619,0.9992985,0.00007164844,0.0001610335,0.0001201609,0.000002554758,0.00001585781,0.000004739248,0.0002480839],"genre_scores_gemma":[0.0004231735,0.9989317,0.0001503555,0.000149453,0.0001493324,0.000002421201,0.00002220888,0.00000100928,0.0001703069],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0034269,"threshold_uncertainty_score":0.01146418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1347478048305354,"score_gpt":0.4533040607868969,"score_spread":0.3185562559563614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}